The aesthetic medicine and treatments sector in the United Kingdom is heading towards a crucial regulatory change for the protection of consumers' mental health. The National Institute for Health and Care Excellence (NICE), a reference body in the British health field, has published a new draft of recommendations aimed at professionals in the clinical and medical-aesthetic field. The central premise of this draft is none other than to formally evaluate patients for possible signs of Body Dysmorphic Disorder (BDD) or Obsessive-Compulsive Disorder (OCD) before performing any aesthetic intervention.
According to the document published by NICE, healthcare professionals and aesthetic treatment applicators must subject clients to a questionnaire with structured questions before any intervention. The objective is to explore possible intrusive thoughts or disproportionate anxieties about physical appearance.
If the preliminary screening raises suspicions that the patient suffers from BDD, a condition characterized by an obsessive and unsustainable preoccupation with supposed physical defects, the professional will have the obligation to refuse to perform the procedure and refer the user to a mental health specialist. "If Body Dysmorphic Disorder is suspected, professionals should not perform the procedure, as this may reinforce or worsen the distress and behaviors associated with the condition," according to the document prepared by NICE.
An underdiagnosed problem and high-risk groups
NICE warns that there is a worrying "underdiagnosis" of these pathologies due to stigma, shame, or fear of social judgment, which causes many patients not to share their obsessions unless directly asked through a structured protocol[cite: 1]. It is estimated that OCD affects approximately 1.2% of the world population, while BDD affects about 2%.
In addition, the new NICE guideline explicitly advises special attention to patients who present with depression or anxiety, and urges consideration of these examinations in people with autism or ADHD (Attention Deficit Hyperactivity Disorder), groups categorized within the most vulnerable group[cite: 1].
Eric Power, interim director of the NICE Guidelines Centre, highlights the urgent need to address the problem early: "People with obsessive-compulsive disorder and body dysmorphic disorder can experience symptoms for a long time before receiving the correct diagnosis and support. Our recommendations seek to help professionals recognize the signs earlier, ask the right questions, and make it easier for patients to access appropriate treatment earlier, preventing them from reaching crisis situations[cite: 1]."
Impact and challenges for the aesthetic medicine sector
For aesthetic medicine clinics, salons, and professionals, this regulatory proposal will mark a before and after in patient admission protocols[cite: 1]:
-
Standardized evaluation protocols: the initial consultation cannot be limited to physical or dermatological suitability, but must obligatorily integrate psychological screening[cite: 1].
-
Staff training in mental health: clinical and medical-aesthetic teams must be trained to identify warning signs of BDD, OCD, or associated neurodivergences[cite: 1].
-
Ethics and responsibility regarding the 'aesthetic addiction' loop: the sector's commitment is reinforced not to profit from or incentivize interventions in patients whose body dissatisfaction is not physical, but psychological, preventing greater psychological sequelae.